ARTICLE / CLIENT ALERT
ISS and Glass Lewis Update Proxy Voting Guidance for COVID-19
April 14, 2020
Read time: 5 min
Institutional Shareholder Services and Glass, Lewis & Co. released revised proxy voting guidelines in light of the Coronavirus (COVID-19) pandemic. This On the Subject details key implications for the 2020 proxy season.
Institutional Shareholder Services Inc. (ISS) and Glass, Lewis & Co., LLC (Glass Lewis) recently updated their respective proxy voting guidelines in response to the Coronavirus (COVID-19) pandemic. As revised, these guidelines have important implications for the 2020 proxy season.
ISS Policy Updates
Annual Meeting Issues
Meeting Postponements: ISS announced that it will take a positive view of companies and boards that use electronic communications (webcasts, conference calls, etc.) to engage with their shareholders even if their annual meetings have been postponed.
Virtual-Only Meetings: ISS does not have a policy to recommend voting against US companies that hold virtual-only shareholder meetings. ISS confirmed that there will be no change to its current approach for the remainder of the 2020 proxy season.
Poison Pills, Shareholder Rights and Boards/Directors
Poison Pills: ISS announced that its existing policy is “appropriately flexible” to account for the adoption of poison pills during the COVID-19 pandemic. The existing policy evaluates poison pills on a case-by-case basis, taking into consideration the board’s rationale and the specific provisions of the poison pill. ISS noted that a severe stock price decline due to the COVID-19 pandemic will likely be considered a valid reason for adopting a pill of less than one year duration without a shareholder vote, provided that the board discloses its rationale.
Director Attendance: ISS noted that telephonic/electronic participation counts as full participation in board and committee meetings for US companies.
Changes to the Board of Directors or Senior Management: ISS announced that its existing policies provide “appropriate discretion and flexibility” to account for changes to boards or senior management. If a board needs to fill vacancies or add critical expertise because of COVID-19, ISS will evaluate the situation on a case-by-case basis.
Compensation Issues
Compensation: ISS encourages boards to provide contemporaneous disclosure to shareholders of their rationale for making material changes to performance metrics, goals or targets used in short-term compensation plans for 2020. Midstream or in-flight changes to awards granted under long-term compensation plans will be evaluated on a case-by-case basis to determine whether boards exercised appropriate discretion and provided adequate explanation to shareholders.
Option Repricing: ISS will apply its existing US benchmark policy on board accountability to repricing actions taken without seeking shareholder approval/ratification in a timely fashion. If a board seeks shareholder approval/ratification of repricing actions, ISS will apply its existing case-by-case approach. ISS generally recommends opposing repricing that occurs within one year of a precipitous drop in the company’s stock price. The factors taken into consideration include whether:
- The design is shareholder value neutral (a value-for-value exchange).
- Surrendered options are not added back to the plan reserve.
- Replacement awards do not vest immediately.
- Executive officers and directors are excluded.
Capital Structure and Payouts
Dividends: ISS supports broad discretion by boards that set payout ratios falling below historic levels or customary market practice.
Share Repurchases: ISS encourages boards to consider the reputational, regulatory and business risks associated with undertaking a share buyback program, even if approved by shareholders. ISS announced that it will consider whether a board appropriately managed risks for any repurchases in 2020.
Share Issuances: ISS will apply is existing case-by-case analysis to general authorization and share issuance requests, but will also adapt the approach for any regulatory relaxations or new guidance as a result of COVID-19. Factors under the existing framework include:
- Proxy statement disclosure of the specific purposes for the proposed increase
- The risks to shareholders of not approving the request
- The size and potential dilutive impact of the request combined with any market-specific guidelines on limits and preemptive rights.
Private Placements: ISS’s existing voting policies provide for case-by-case analysis of private placement issuances considering:
- The rationale for the private placement issuance
- The potential dilution to existing shareholders
- The discount/premium in issuance price to the unaffected share price before the announcement of the private placement
- Any conflicts of interest
- Consideration of alternatives
- The market’s reaction to the proposed private placement since announcement.
ISS also will consider whether there are any exceptional circumstances.
Glass Lewis Policy Updates
Virtual Shareholder Meetings: Glass Lewis announced a change to its standard policy on virtual-only shareholder meetings. For companies holding virtual-only shareholder meetings because of COVID-19, Glass Lewis will generally refrain from recommending to vote against the governance committee members so long as the company discloses its rationale, including citing COVID-19. Glass Lewis will revert to its standard policy for virtual meetings occurring after the 2020 proxy season.
Key Concerns for Wind Projects During COVID-19: Part 2
ARTICLE
Key Concerns for Wind Projects During COVID-19: Part 2
April 14, 2020
Read time: 1 min

Videoconferencing: Tips for Schools to Navigate Security and Privacy Risks
ARTICLE / CLIENT ALERT
Videoconferencing: Tips for Schools to Navigate Security and Privacy Risks
April 14, 2020
Read time: 24 min
The COVID-19 pandemic has resulted in a dramatic increase in the use of web-based video and audio conferencing (“WC”) services by schools, as most, if not all, schools have been closed and students are attending virtual classes from home. While the availability of this technology is not new, and in fact has been widespread in some industries for several years, many schools are adopting WC for the first time or relying on it in new ways. With its expanded adoption and use, the security and privacy issues associated with the use of WC technology have come into the spotlight. For example, Zoom has become subject to attorney general inquiries in New York, Connecticut and Florida and several lawsuits citing security and privacy concerns.[1]
On March 30, 2020, the FBI’s Boston field office issued a warning after numerous accounts of WC hijacking, colloquially referred to as “Zoombombing” or “Zoom raiding,” with an emphasis on two incidents involving schools in Massachusetts, namely:
- In late March 2020, a Massachusetts-based high school reported that while a teacher was conducting an online class using the teleconferencing software Zoom, an unidentified individual(s) dialed into the classroom. This individual yelled a profanity and then shouted the teacher’s home address in the middle of instruction.
- A second Massachusetts-based school reported a Zoom meeting being accessed by an unidentified individual. In this incident, the individual was visible on the video camera and displayed swastika tattoos.[2]
As a result of these concerns, on April 4, 2020, the New York City Department of Education ordered its teachers to stop using the videoconferencing platform Zoom, at least until the data privacy and security issues are resolved.[3] In addition to schools, instances of hijacking reported in the media have focused on the use of WC by religious groups and public service organizations such as AA, where intruders have posted hateful, pornographic or otherwise offensive and disruptive content, often by exploiting a publicly-posted meeting link.[4]
These alarming developments highlight the serious concerns presented by the use of WC services for distance learning, where unauthorized access could disrupt and disturb classes and lessons. Unauthorized access also has implications for the privacy of students and faculty, whose personal information may be discussed or displayed during a lesson or one-on-one meeting between a student and a teacher.
Finally, schools should be aware that use of third-party WC service providers for distance learning may raise compliance issues under the Children’s Online Privacy Protection Act (“COPPA”). COPPA only applies to operators of commercial websites and online service providers, so it generally does not impose obligations on schools. However, the Federal Trade Commission (“FTC”) issued guidance on April 9, 2020, indicating that, in the educational context, schools can consent on behalf of parents to the collection by WC service providers of student personal information under certain circumstances.[5] Accordingly, with WC service providers likely to look to schools to obtain consent under COPPA, school administrators should be aware of best practices in this area as well.
As discussed in this Alert, there are a variety of measures schools can take to mitigate the security, privacy and indirect compliance risks associated with conducting distance learning through the use of WC services.
WC Services Technology
Generally speaking, WC services use software and hardware to permit remote users to connect and exchange live video, audio and written content, through laptops, desktops, smart phones and similar computerized devices. WC vendors provide users with the software and hardware that enables such communications. WC software offers users various features, which vary across service providers, but typically include access controls (used by a host to manage participant access to a meeting), meeting recording, screen sharing and live chat among the users.
Best Practices for WC Platforms
Many schools are using Zoom, Microsoft Teams or Google Meet for their WC solutions. Irrespective of the platform utilized, however, school administrators should evaluate their use of WC services and adopt reasonable measures to protect the security and privacy of WC communications. Below is a list of best practices, compiled based on guidance from the FBI and IT experts, that can serve as points of reference:
1. Run the Latest Version of WC Software. WC service providers periodically release new versions of, and updates to, WC software that are intended to address security vulnerabilities, fix known bugs or provide new features or functions (some of which may be useful in improving the security of the WC services). Updating to the latest version of software is critical to keeping in step with bad actors as they find new ways to hack or disrupt WC services.
2. Configure the WC Software with Robust Security Controls. Although specific features vary by service provider, WC software generally contains controls that give a meeting host substantial control over an invited participant’s access to and use of the WC services. When setting up an account, consider establishing defaults that enhance the security of meetings and don’t allow the default settings to be changed, such as:
a. Use Unique Meeting IDs. A meeting ID is one piece of information that is used to gain access to a particular meeting. In some WC configurations, meeting IDs are associated with specific users rather than with specific meetings (so all meetings initiated by a user have the same meeting ID). To prevent unauthorized access by persons who received the meeting ID for a prior meeting held by the same host, configure the WC software to generate a unique meeting ID every time a new meeting is created.
b. Require Passwords. Some WC services may permit participant access to a meeting without a password. Require strong passwords for meeting access and do not allow passwords to be disabled by individual users.
c. Use Multifactor Authentication. If available, use multifactor authentication for the meeting host.
d. Use Meeting Access Controls. WC services allow the host to control participants’ access to a WC meeting. Wherever feasible, hosts should leverage these controls to enhance meeting security as follows:
i. Waiting Rooms. Waiting rooms allow a host to virtually assemble participants before starting a meeting. Using this feature allows the host the opportunity to validate that only invited participants have joined the meeting before any information is shared.
ii. Meeting Locks. Meeting locks allow the host to restrict a participant’s access to a meeting until the host has started the meeting and to prevent any new participants from joining a meeting after it has started.
iii. Other Tools. Some WC services allow a host to mute specific participants or remove them altogether from a meeting. Hosts should be prepared to use those tools as necessary to protect the integrity of a lesson or other meeting.
e. Turn off Screen Sharing. WC services allow teachers and other participants to share their screens. Consider disabling the screen sharing function for all participants except for the host and any other presenters, unless it is required.
f. Turn off Recording. If a WC service allows a meeting to be recorded for playback, disable this feature. If a meeting needs to be recorded, to retain for purposes such as asynchronous learning, consider disabling the recording feature for all participants except for the host and, after the meeting ends, ensure the host downloads a copy.[6]
g. Turn off Chat. Many WC services permit participants to chat by live text. Disable this feature unless it is necessary for the lesson. If chat is enabled, it should be configured so that only messaging among the host and all participants (vs. private messaging between participants) is permitted.
h. File Sharing Settings. If a WC service allows file sharing, disable this feature unless it is necessary for a lesson and an alternate school-approved resource, such as Google Docs, is not available.
3. Use an Enterprise Solution with Sufficient Security Features. WC vendors provide both personal (or “consumer”) and enterprise versions of their software, and many vendors offer versions specifically for schools. Schools should purchase an enterprise solution that supports a sufficient number of participants and provides the necessary functionality, including features designed to enhance security and privacy. Free or lower-cost consumer versions often lack a full set of security controls and embed advertising that increases the risk of a security breach and unauthorized collection of personal information from students or other participants.
4. Claim and Manage Your Domain. If a WC service allows, claim your organization’s email address domain (such as @srz.com) when adding users to your WC services account. Users with the specified domain (e.g., teachers and administrators) will be prompted to join your WC services account and, therefore, be held to the security and privacy configurations set at an enterprise level.
5. Educate Faculty, Students and Parents. Send a communication to faculty, students and parents about the potential risks associated with WC services and best practices, including direction on how to use the controls discussed above. Send updates and reminders to recipients, particularly if the risk may be elevated (e.g., reports of a pervasive hacking scheme).
6. Conduct Diligence on and Monitor WC Vendors. Schools should remember to conduct and document the findings of cyber diligence on WC vendors, as for any other information technology vendors.[7] Diligence should be conducted not only when the vendor is engaged but also on a periodic basis thereafter. Schools should also stay up to date on threat communications and responses from WC vendors. WC-related security and privacy issues tend to arise with relative frequency and, similarly, are addressed by vendors on an ongoing basis. Since the COVID-19 pandemic hit, many WC vendors have changed or clarified their privacy practices and issued tips for enhanced security.
COPPA Issues
According to the FTC, schools can consent on behalf of parents to the collection of student personal information — but only if such information is used for a school-authorized educational purpose and for no other commercial purpose.[8] In order for a WC service provider to get consent from a school instead of from the parent, the service must provide the school the necessary COPPA-required notice of its data collection and use practices.[9]
In addition, the FTC has provided guidance with respect to best practices, summarized as follows:
1. Disclosure to Parents. Identify the WC service provider(s) and services whose collection of children’s information the school has consented to, make available to parents in plain, easily understood language, the WC service provider’s notice about its data collection and use policies and, where feasible, let parents review the personal information collected.
2. Do Not Let Individual Teachers Select the WC Service Provider. Schools should decide whether a particular site’s or service’s privacy and information practices are appropriate, rather than delegating that decision to individual instructors.
3. Perform Diligence on WC Service Providers. In deciding which online technologies to use with students, a school should be careful to understand how an operator will collect, use and disclose personal information from its students. Among the questions that a school should ask potential operators are:
- What types of personal information will you collect from students?
- How do you use this personal information?
- Do you use or share the information for commercial purposes not related to the provision of the online services requested by the school? For instance, do you use students’ personal information in connection with generating targeted advertising or building user profiles for commercial purposes not related to the provision of the online service? If so, the school cannot consent on behalf of the parent.
- Do you let the school review and have deleted the personal information collected from their students? If not, the school cannot consent on behalf of the parent.
- What measures do you take to protect the security, confidentiality and integrity of the personal information that you collect?
- What are your data retention and deletion policies for children’s personal information?
With the use of WC services by schools to conduct distance learning likely to continue for most, if not all, of the spring semester, schools are advised to take a close look at how they implement this technology to address appropriately security and privacy risks.
Authored by Mark E. Brossman, Edward H. Sadtler, John C. Garces, Scott M. Kareff, Kelly Koscuiszka and Donna K. Lazarus.
If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.
[1] See, e.g., “States probe Zoom for possible privacy violations after officials’ calls are Zoombombed;” https://www.cnet.com/news/zoom-every-security-issue-uncovered-in-the-video-chat-app/.
[2] See “FBI Warns of Teleconferencing and Online Classroom Hijacking During COVID-19 Pandemic.”
[3] See “NYC Schools Chancellor Richard Carranza tells teachers to stop using Zoom for remote learning due to security concerns;” “School districts reportedly ban Zoom over security issues.”
[4] See, e.g., https://www.nytimes.com/2020/04/03/technology/zoom-harassment-abuse-racism-fbi-warning.html.
[5] See “COPPA Guidance for Ed Tech Companies and Schools during the Coronavirus.”
[6] Schools should provide guidance to personnel about whether/when to record video conferences, as well as how copies of videoconferences are stored, for how long and who can access them based on the nature of the lesson or meeting.
[7] For example, schools should review the service provider’s terms of use and privacy policies to confirm they contain limited use rights that state the service provider has access to the content only to the extent needed to provide the WC service to the organization. Most WC service providers, including Zoom, Microsoft Teams and Google Meet, have user policies that make clear that, as between the vendor and the customer, the customer owns and controls (and is responsible for) the content of the meetings. Additionally, schools that plan to store recordings with the service provider should review the service provider’s terms of use to understand how long the service provider will maintain a copy of the recordings (typically 30 days) and the user’s rights, if any, to obtain copies of those recordings.
[8] See footnote 5.
[9] The online notice must state the following three categories of information (1) the name, address, telephone number and email address of all operators collecting or maintaining personal information through the site or service (or, after listing all such operators, provide the contact information for one that will handle all inquiries from parents); (2) a description of what information the operator collects from children, including whether the operator enables children to make their personal information publicly available, how the operator uses such information and the operator’s disclosure practices for such information; and (3) that the parent can review or have deleted the child’s personal information and refuse to permit its further collection or use, and state the procedures for doing so. See Section C of the FTC’s COPPA FAQs.
This is a fast-moving topic and the information contained in this Alert is current as of the date it was published.
This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2020 Schulte Roth & Zabel LLP.
All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

California Property Tax Relief Options in the Wake of COVID-19
ARTICLE
California Property Tax Relief Options in the Wake of COVID-19
April 13, 2020
Read time: 1 min
COVID-19 Considerations: Hospitals & Health Systems
ARTICLE
COVID-19 Considerations: Hospitals & Health Systems
April 2020
Read time: 2 min
The impact of Coronavirus (COVID-19) on hospitals and health systems is unprecedented. On the frontlines combatting the pandemic, the industry is also facing a financial crisis and a rapidly evolving regulatory and legal landscape. The need to make thoughtful but quick decisions has never been greater.
On the legal and regulatory front, McDermott’s multidisciplinary team is closely tracking and analyzing developments related to COVID-19 to provide thoughtful, practical advice to help our clients in these turbulent times. Based on this ongoing work, and the industry’s business and operational priorities, we have created this guide to highlight some of the most critical issues for hospitals and health systems to consider. This high-level format is designed to allow legal teams, management, board members and others at your organization to quickly digest the latest developments, view more detailed summaries and analysis at the links provided, and take appropriate actions.
Key Concerns for Wind Projects During COVID-19: Part 1
ARTICLE
Key Concerns for Wind Projects During COVID-19: Part 1
April 13, 2020
Read time: 1 min
Action Step Considerations for Life Sciences Companies Amidst the COVID-19 Pandemic
ARTICLE
Action Step Considerations for Life Sciences Companies Amidst the COVID-19 Pandemic
April 2020
Read time: 2 min
The impact of Coronavirus (COVID-19) on life science and medical device companies has been unique. Not only have these businesses been required to set up emergency management systems practically overnight to maintain normal business operations, but the sector is expected to make significant contributions to the fight against COVID-19 across the globe.
With new challenges arising each day, as well as regulatory changes and mounting pressure on the healthcare ecosystem, we are closely tracking, digesting and advising life sciences clients on COVID-19-related issues across virtually every area impacted by this crisis. We are currently advising life sciences, healthcare and technology companies as they adapt their products and services and indeed their facilities and distribution channels to aid in the pandemic response, maintain commercial viability, implement risk mitigation strategies, and navigate highly complex regulatory hurdles and compliance obligations.

Regulated Funds: SEC Issues Order Providing Flexibility to Business Development Companies to Issue and Sell Senior Securities and to Participate in Certain Joint Arrangements
ARTICLE / CLIENT ALERT
Regulated Funds: SEC Issues Order Providing Flexibility to Business Development Companies to Issue and Sell Senior Securities and to Participate in Certain Joint Arrangements
April 13, 2020
Read time: 12 min
On April 8, 2020, the U.S. Securities and Exchange Commission issued an order (“Order”) providing temporary exemptions from certain requirements imposed on business development companies (“BDCs”) by the Investment Company Act of 1940, as amended (“1940 Act”).[1] The action was taken by the SEC in response to the “far-reaching and unanticipated effects” of the COVID-19 pandemic on financial markets, and particularly credit markets. The exemptions provided for in the Order enable BDCs to (i) issue and sell senior securities and (ii) engage in joint enterprises or joint arrangements that would otherwise be prohibited.[2]
Recognizing that BDCs are likely to face challenges during the COVID-19 pandemic in providing capital to the portfolio companies in which they invest, the SEC issued the Order in an effort to prevent (i) the inability of a BDC to satisfy 1940 Act asset coverage requirements due to temporary mark-downs in the value of loans made by a BDC to a portfolio company and (ii) certain BDC affiliates from being restricted from participating in additional investments in a BDC’s portfolio companies due to restrictions in the BDC’s current exemptive order permitting co-investments. The SEC appears to anticipate that the challenges faced by BDCs during the COVID-19 pandemic may continue into late 2020 and the exemptions provided for in the Order will remain in effect until at least Dec. 31, 2020 (“Exemptive Period”). Notably, however, certain conditions for reliance on the Order, including public disclosure of a BDC’s intent to do so, may limit the number of BDCs that elect to utilize the relief the Order provides.
Issuance and Sale of Senior Securities
The Order provides a BDC the ability during the Exemptive Period to modify how its asset coverage ratio is calculated, which could enable certain BDCs to more easily issue or sell senior securities. A BDC’s asset coverage ratio refers to the ratio of a BDC’s total assets compared to its aggregate amount of outstanding senior securities. Section 61(a)(1) of the 1940 Act imposes a 200% asset coverage requirement in respect of any senior security issued by a BDC.[3] Section 61(a)(2) of the 1940 Act allows BDCs meeting certain specified conditions to elect to decrease their effective asset coverage requirement to 150%, representing approximately a 2-to-1 debt-to-equity ratio.[4] While a BDC will remain subject to the asset coverage requirements of these sections of the 1940 Act, as well as to the requirements of Section 18(b) of the 1940 Act, during the Exemptive Period the Order permits the calculation of asset coverage ratio to be adjusted using asset values generated prior to the current COVID-19 crisis, subject to certain conditions, as described below:
- Adjusted Portfolio Value. In connection with the issuance or sale of a covered senior security, the Order permits a BDC to modify the calculation of its asset coverage ratio with respect to portfolio company holdings (i) that the BDC held at Dec. 31, 2019; (ii) that the BDC continues to hold at the time of such issuance or sale; and (iii) for which the BDC is not recognizing a realized loss.[5] In connection with the adjusted calculation, the BDC may use values calculated as of Dec. 31, 2019 to calculate portfolio value (“Adjusted Portfolio Value”) to meet an adjusted asset coverage ratio (“Adjusted Asset Coverage Ratio”). In order to calculate its Adjusted Asset Coverage Ratio, a BDC must reduce its asset coverage ratio using the Adjusted Portfolio Value by an amount equal to 25% of the difference between the asset coverage ratio calculated using the Adjusted Portfolio Value and the asset coverage ratio that would normally be calculated in accordance with section 18(b) of the 1940 Act.
- Election. Before first engaging in the issuance or sale of a senior security in reliance on the Order, a BDC must publicly announce that it has made an election to do so on Form 8-K.
- Limitation on New Investments. A BDC that has elected to rely on the Order cannot, for a period of 90 days from the date of its election, make an initial investment in a portfolio company in which the BDC was not already invested as of the date of the Order, provided that a BDC may make an initial investment in such a portfolio company if at the time of investment its asset coverage ratio complies with the asset coverage ratio applicable to it under Sections 18 and 61 of the 1940 Act, without taking into account the modifications provided for under the Order.
- Board Approval of Reliance on this Order. Prior to a BDC’s election to rely on the Order, its board of directors (“Board”), including a required majority of the Board, as defined in section 57(o) of the 1940 Act (“Required Majority”), must determine that the issuance or sale of senior securities is permitted by the Order and is in the best interests of the BDC and its shareholders.
- Board Approval of Each Issuance of Senior Securities. Prior to each time a BDC issues or sells senior securities in reliance on the Order, the Board, including a Required Majority, must determine that such issuance is in the best interests of the BDC and its shareholders. Before making that determination, the Board must obtain and consider (i) a certification from the BDC’s investment adviser that the issuance of such senior securities is in the best interests of the BDC and its shareholders;[6] and (ii) advice from an “Independent Evaluator”[7] regarding whether the terms and conditions of the proposed issuance or sale of a senior security are fair and reasonable compared to similar issuances, if any, by unaffiliated third parties in light of current market conditions.
- No Sunset Period. The Board of a BDC that has elected to rely on the Order is required to receive and review, no less frequently than monthly, reports prepared by the BDC’s investment adviser regarding and assessing the efforts that the investment adviser has undertaken, and progress that the BDC has made, towards achieving compliance with the normal asset coverage requirements under Section 18 and Section 61 of the 1940 Act (without regard to the relief provided by the Order), by the expiration of the Exemptive Period. Upon expiration of the Exemptive Period, a BDC that is non-compliant with the normal asset coverage requirements under the 1940 Act will be required to immediately file a Form 8-K that includes (i) the BDC’s current asset coverage ratio; (ii) the reasons the BDC was unable to comply with the asset coverage requirements; (iii) the time frame within which the BDC expects to come into compliance with the asset coverage requirements; and (iv) the specific steps that the BDC will be undertaking to bring itself into compliance with the asset coverage requirements.
- Recordkeeping. A BDC is required to make and preserve, for a period of not less than six years, minutes describing (i) a Board’s deliberations in connection with its approval of an issuance of senior securities, including the factors considered by the Board in connection with such determinations, as well as all information, documents and reports provided to the Board in connection with its determination; and (ii) any presentations made to the Board related to the requirements noted above, including copies of all other information provided to or relied upon by the Board.
- No Compensation or Remuneration of Any Kind. Except (i) to the extent permitted by Section 57(k) of the 1940 Act; or (ii) for payments or distributions made by an issuer to all holders of a security in accordance with the security’s terms, no affiliated person of a BDC, nor any affiliated person of such a person, may receive any transaction fees (including break-up, structuring, monitoring or commitment fees) or other remuneration from an issuer in which a BDC invests during the Exemptive Period. However, this limitation does not apply to the receipt of investment advisory fees by an investment adviser to a BDC.
Further, the Order provides relief only for the issuance or sale of senior securities representing indebtedness or the issuance of stock by a BDC, but does not provide relief for declarations or payments by a BDC of any dividend or any other distribution that may pose a violation under Sections 18 or 61 under the 1940 Act.
Given the narrow scope of the relief granted under the Order with respect to the asset coverage test under the 1940 Act, and the public disclosure requirement applicable to BDCs that opt to rely on such relief, many existing BDCs may wish to refrain from opting into the asset coverage ratio relief provided for under the Order unless they face a significant risk of violating the normal asset coverage ratio requirement under the 1940 Act as a result of widespread market-related decreases in the fair value of their portfolio assets. In particular, those BDCs that opt in to the relief may face negative market perceptions to the extent most BDCs elect not to do so. It may be prudent, though, for BDCs to carefully review the wording of the leverage requirements included in any credit facilities or debt instruments they have outstanding to determine what, if any, impact the Order may have on such third-party leverage requirements to the extent a BDC does decide to opt in to the asset coverage ratio relief under the Order.
Expansion of Relief for BDCs with Existing Co-Investment Orders
During the Exemptive Period, a BDC that has previously been issued a co-investment order by the SEC (“Existing Co-Investment Order”), may engage in certain joint enterprises or joint arrangements that may be prohibited by Section 57(a)(4) of the 1940 Act and Rule 17d-1 thereunder. Subject to the Order, a BDC with an Existing Co-Investment Order may participate in a Follow-On Investment[8] (which may include a Non-Negotiated Follow-On Investment) with one or more Regulated Funds and/or Affiliated Funds, provided that (i) if such participant is a Regulated Fund, it has previously participated in a Co-Investment Transaction with the BDC with respect to the issuer; and (ii) if such participant is an Affiliated Fund, it either (X) has previously participated in a Co-Investment Transaction with the BDC with respect to the issuer or (Y) is not invested in the issuer.
The Order also establishes the following Board oversight requirements for BDCs that are engaged in co-investment transactions with affiliates in reliance on the exemptions provided for in the Order.
- Non-Negotiated Follow-On Investments. Non-Negotiated Follow-On Investments do not require prior approval by the Board. However, a Board remains subject to the periodic reporting requirements established in an Existing Co-Investment Order.
- Follow-On Investments Other than Non-Negotiated Follow-On Investments. In connection with all findings required by an Existing Co-Investment Order with respect to Follow-On Investments that are not Non-Negotiated Follow-On Investments, the Board, and a Required Majority, are required to review the proposed Follow-On Investment, both on a stand-alone basis and in relation to the total economic exposure of the BDC to the issuer.
Notably, the temporary co-investment relief provided for under the Order may provide slightly greater latitude for a BDC facing capital constraints to permit certain affiliates to help fund necessary follow-on investments in potentially struggling portfolio companies.
The Order is one in a series of actions taken by the SEC aimed at mitigating the impact of COVID-19 on financial market participants. In issuing this temporary, emergency order, the SEC has taken a significant step in granting flexibility to BDCs to offer capital and liquidity to portfolio companies that may be impacted significantly by the COVID-19 pandemic. If you have any questions about the content of this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.
Authored by Karen Spiegel and Noah B. Aschen.
[1] Investment Company Act Release No. 33837 (April 8, 2020), available here.
[2] Section 57(a)(4) of the 1940 Act and Rule 17d-1 prohibit a BDC from engaging in a “joint enterprise or other joint arrangement or profit-sharing plan” with affiliates of the BDC unless an exemptive order has been received by the BDC pursuant to Section 57(c).
[3] 15 U.S.C. § 80a–60
[4] See “New BDC Opportunities: How the Passage of the Small Business Credit Availability Act Will Benefit Both New and Existing Business Development Companies,” April 4, 2018, available here.
[5] A Dec. 31, 2019 value cannot be used for a portfolio company that has become “permanently impaired,” as defined in the Order.
[6] Such certification must include the reasons for the investment adviser’s recommendation, including whether the adviser has considered other reasonable alternatives that would not result in the issuance or sale of a covered senior security.
[7] The term “Independent Evaluator” is defined as a person with expertise in the valuation of securities and other financial assets and who is not an “interested person,” as such term is defined in section 2(a)(19) of the 1940, of the BDC, or any affiliate thereof.
[8] Pursuant to the Order, the terms “Follow-On Investments,” “Regulated Funds,” “Affiliated Funds” and “Co-Investment Transaction” have the meanings ascribed to them in the relevant Existing Co-Investment Order. For purposes of the Order, the term Affiliated Fund does not include any open or closed-end investment company registered under the 1940 Act or a BDC. “Non-Negotiated Follow-On Investments” also has the meaning ascribed to it in the relevant Existing Co-Investment Order, notwithstanding that a BDC may participate in a Non-Negotiated Follow-On Investment in reliance on the Order whether or not such term is used in its Existing Co-Investment Order.
This is a fast-moving topic and the information contained in this Alert is current as of the date it was published.
This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2020 Schulte Roth & Zabel LLP.
All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.
Flexibilities for DMEPOS, Laboratories and Ambulances During COVID-19
ARTICLE / CLIENT ALERT
Flexibilities for DMEPOS, Laboratories and Ambulances During COVID-19
April 10, 2020
Read time: 6 min
The Centers for Medicare and Medicaid Services (CMS) released fact sheets and subsequent guidance detailing regulatory flexibilities for suppliers of Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), Laboratories and Ambulances during the Coronavirus (COVID-19) pandemic. The additional flexibilities help to expand and expedite access to COVID-19 testing and allow certain healthcare providers to provide necessary services more quickly and efficiently during the national emergency.
CMS recently released guidance for multiple provider types as part of its broad package of blanket Section 1135 waivers, providing additional regulatory flexibility during the Coronavirus (COVID-19) pandemic national emergency. A summary of the scope of additional flexibility afforded to DMEPOS suppliers, laboratories and ambulances follows.
Blanket Waiver Package
CMS’ broad package of Section 1135 waivers issued on March 30, 2020 (summarized here) builds upon a more limited set of waivers issued on March 13, 2020 (analyzed here). Additional guidance was issued on April 9, 2020, in the form of further updates to a provider fact sheet and provider FAQs that reflect information in the Interim Final Rule and Comment issued on March 30, 2020 (as expanded, FAQs). The updated waivers and guidance address common concerns among providers and suppliers nationwide, including waivers to allow expansion of availability of needed healthcare services and increased COVID-19 testing capabilities. CMS also clarified that in order to operate under COVID-19-related blanket waivers, Medicare-enrolled providers and suppliers need not provide written notice of intent to do so.
Durable Medical Equipment, Prosthetics, Orthotics, and Supplies
Generally, when DMEPOS is lost, destroyed, irreparably damaged or otherwise unusable, CMS, through the Medicare Administrative Contractors (MACs), requires suppliers to meet specific requirements in order to obtain replacement DMEPOS. For the duration of the COVID-19 pandemic, CMS is allowing MACs to offer suppliers seeking replacement DMEPOS temporary flexibility to refrain from adhering to the “face-to-face” requirement and the requirements to obtain a new physician’s order and new medical necessity documentation. Suppliers must still include a narrative description on the claim explaining the reason for replacement and noting that documentation is unavailable as the result of the emergency.
CMS is also pausing the national Medicare Prior Authorization program for certain DMEPOS items and is not requiring accreditation for newly enrolling DMEPOS suppliers. Expiring supplier accreditation is extended for a 90-day time period. In addition, DMEPOS suppliers will not have to adhere to signature and proof of delivery requirements when the supplier is unable to obtain a signature. Suppliers should document the date of delivery and inability to obtain a signature due to COVID-19 in the medical record.
See the DMEPOS Flexibility Fact Sheet here.
Laboratories
The new flexibilities offered to laboratories by CMS include measures to expand access to and payment for COVID-19 testing, and clarifies the locations where testing can occur. CMS has also provided that during the COVID-19 pandemic emergency, Medicare will pay a specimen collection fee for travel associated with a laboratory technician’s collection of a sample for COVID-19 testing at a beneficiary’s home, including a nursing home. The FAQs identify new Healthcare Common Procedure Coding System codes for specimen collection for COVID-19, effective February 4, 2020. The fees are $23.46 for homebound individuals and $25.46 for individuals in a skilled nursing facility or who are part of a home health agency. A home health nurse or visiting nurse already treating the beneficiary pursuant to a Medicare-covered visit can obtain a sample to send to the laboratory for COVID-19 diagnostic testing.
CMS clarified in the FAQs that “homebound” patients for purposes of Medicare payment include those patients where a physician has determined that it is medically contraindicated for a beneficiary to leave the home because (1) the patient has a confirmed or suspected diagnosis of COVID-19; or (2) because the patient has a condition that may make the patient more susceptible to contracting COVID-19. A patient who is exercising “self-quarantine” for one’s own safety would not be considered “confined to the home” unless a physician certifies that it is medically contraindicated for the patient to leave the home.
To help facilitate the expansion of COVID-19 testing capabilities, CMS also clarified that it will exercise enforcement discretion to facilitate pathologists’ ability to review pathology slides remotely; expedite review of CLIA certificates and applications to ensure laboratories wishing to perform COVID-19 testing can begin to do so as quickly as possible; allow laboratories within a hospital/university hospital campus to hold a single certificate for the laboratory sites within the same physical location or street address; and allow alternate specimen collection devices and media to be used to collect and transport COVID-19 samples.
See the Laboratories Flexibility Fact Sheet here. CMS released additional FAQs on Laboratory COVID-19 testing services as part of the FAQs, here.
Ambulances
CMS is temporarily expanding the list of allowable destinations for ambulance transports to include any destination that is able to provide treatment to the patient in a manner consistent with state and local emergency medical services (EMS) protocols in use where the services are being furnished. Locations may include alternative sites determined to be part of a hospital, SNFs, community mental health centers, federally qualified health centers (FQHCs), physician’s offices, urgent care facilities, ambulatory surgery centers (ASCs), the beneficiary’s home and any other location furnishing dialysis services. CMS clarified in the FAQs that Medicare will pay for ambulance transportation to approved locations according to the usual payment guidelines.
CMS is also offering states involved in the Repetitive Scheduled Non-Emergent Ambulance Transports demonstration the option of pausing participation for the duration of the COVID-19 emergency.
See the Ambulances Flexibilities Fact Sheet here. The FAQs include those related to Ambulance services.
Common Waivers to all Provider Types
In addition to the above-listed waivers, like other Medicare providers, DMEPOS, laboratories and ambulances are also eligible for accelerated/advanced payments from Medicare. The Accelerated and Advance Payment Program provides immediate cash payments to eligible providers of amounts up to the amount of payments received from Medicare during the last quarter of 2019. For more information on the program, see our prior article “CMS Expands Accelerated and Advance Payment Program to All Medicare Providers, Suppliers.”
CMS also clarifies several Medicare appeals procedures for providers and suppliers enrolled in Medicare Fee for Service (FFS), Medicare Advantage (MA) and Part D plans, including the opportunity to obtain extensions to file appeals. Separate requirements apply depending on the Medicare programs.
Key Takeaways
For the period of the COVID-19 national emergency, CMS has afforded DMEPOS, laboratories and ambulances the ability to expand and provide related services more quickly and efficiently. CMS is waiving several requirements previously applicable to replacement of DMEPOS, offering laboratories greater flexibility to expand access to COVID-19 testing services and expanding the allowable list for ambulance transports.

Medicare Resources and Information for Home Health and Hospice Agencies During the COVID-19 Pandemic
ARTICLE / CLIENT ALERT
Medicare Resources and Information for Home Health and Hospice Agencies During the COVID-19 Pandemic
April 10, 2020
Read time: 11 min
The Centers for Medicare and Medicaid Services (CMS) recently provided Section 1135 waivers and guidance granting flexibilities to home health agencies (HHAs) and hospices during the Coronavirus (COVID-19) pandemic national emergency.
Of note are an expanded ability for HHAs and hospices to provide some telehealth services to Medicare beneficiaries as well as the easing of certain administrative requirements for determination and certification of eligibility for Medicare patients to receive home health and hospice services. Like other Medicare providers, HHAs and hospices are also eligible for accelerated/advanced payments from Medicare, and HHAs may be able to utilize the blanket Stark Law waivers for COVID-19-related purposes.
Background
On March 13, 2020, President Donald Trump declared a national emergency under the National Emergencies Act and made an emergency determination under the Stafford Act. This announcement followed the January 31, 2020, declaration of a public health emergency under the Public Health Service Act by the Secretary of the US Department of Health and Human Services (HHS). These actions opened the door for the authorization of waivers of certain Medicare, Medicaid and Children’s Health Insurance Program (CHIP) requirements as provided by Section 1135 of the Act (collectively, Section 1135 waivers).
Section 1135 of the Act allows the Secretary to temporarily waive certain, but not all, healthcare regulatory requirements in an emergency area during an emergency period. To implement Section 1135 waivers, CMS must determine that a provider has been affected by the emergency that prompted the issuance of the waivers. CMS has the option to issue individual Section 1135 waivers on a case-by-case basis, or CMS can implement “blanket” waivers.
Section 1135 waivers typically end either at the termination of the emergency period or 60 days from the date that the waiver or modification is published. With notice, HHS may provide for additional periods of up to 60 days until the end of the emergency period. For more information on Section 1135 waivers, see our previous On the Subject.
In Depth
HHAs and hospice providers play an important role in caring for patients in the home setting. The COVID-19 pandemic has created new challenges for HHAs and hospices operating in these settings, in particular due to widespread quarantines, remote work and provider shortages. CMS has issued Section 1135 waivers and guidance in the form of fact sheets for HHAs and hospices that detail flexibilities afforded to HHAs and hospice providers during the public health emergency.
1. Home Health Agencies
Changes to “Homebound Status”
CMS has temporarily revised the definition of “homebound” to include Medicare patients for whom: (1) a physician has determined it is medically necessary for that patient to remain home because he/she has been diagnosed with COVID-19; or (2) a physician has determined that is it medically necessary for the patient to remain home because he/she has a condition that may make the patient more susceptible to contracting COVID-19.
Because the CDC is advising older adults to remain home during the outbreak, CMS expects that this will render a large number of Medicare beneficiaries “homebound.” However, a physician’s certification in the patient’s medical record is essential; self-quarantine or social distancing alone is not sufficient to render a Medicare patient “homebound” for this purpose. Under the new telehealth waiver, CMS will allow the face-to-face encounter with a physician or an allowed non-physician practitioner to be performed via telehealth to the patient’s home or other originating site. As noted in the next section, initial assessments can be conducted by the HHA remotely or by record review. CMS notes in the Interim Final Rule (IFC) that this clarification is not limited to the COVID-19 pandemic, but could apply to other outbreaks of infectious disease, and solicits comments to that point.
Initial Assessments; OASIS Reporting
CMS has also waived the requirement that HHAs perform initial assessment visits with Medicare beneficiaries to determine eligibility for the benefit and the patient’s homebound status. This initial assessment can now be conducted remotely or by record review by the HHA. CMS indicates that this will make available scarce physicians and advanced practice clinicians and enable them to provide direct patient care rather than focusing on administrative tasks.
CMS has also permitted occupational therapists (OTs) to perform initial and comprehensive assessments for all Medicare patients receiving occupational therapy as part of the plan of care, regardless of whether occupational therapy is the service that establishes eligibility for care. OTs can only perform this assessment when occupational therapy is part of the plan of care; OTs and other therapists are not permitted to perform the assessment in nursing-only cases. OTs must only perform the assessment if it is within their state scope of practice laws and must access other professionals (e.g., nurses) for portions of the assessment outside of their scope of practice.
Additionally, CMS has extended timeframes for HHAs to report via CMS’ Outcome and Assessment Information Set (OASIS). The waiver extends the 5-day completion requirement for the comprehensive assessment and waives the 30-day OASIS submission requirement. CMS will continue to require that HHAs assess patients to determine and appropriately meet their care needs; HHAs are expected to complete the comprehensive assessment within 30 days, and delayed submission is permitted during the public health emergency.
Telehealth
CMS reiterated that it is statutorily prohibited from paying for home health services furnished via telecommunications if those telehealth services are provided in lieu of in-person home health services ordered as part of the Medicare patient’s plan of care. During the public health emergency, however, CMS is temporarily allowing HHAs to use telehealth—in addition to remote monitoring—to provide services to patients, but only if the use of technology is related to the skilled services being furnished by a nurse, therapist or therapy assistant to optimize the services furnished during the home visit or when there is a home visit. For the purposes of Medicare payment, the plan of care must include a description of how the use of the technology will help achieve goals in the plan of care without substituting for in-person visits ordered in the plan of care. Services provided via telemedicine cannot be considered a home visit for the purposes of patient eligibility or payment, but HHAs can report the costs of telecommunication technology as allowable administrative and general costs on an interim basis.
Plans of Care; Certifying and Recertifying Eligibility; Onsite Supervision
In light of potential workforce shortages due to the public health emergency, CMS will temporarily allow Medicare patients to be under the care of a nurse practitioner (NP), clinical nurse specialist (masters-level RN) or a physician assistant (PA) who is working in accordance with state law and permits such practitioner to: (1) order home health services; (2) establish and periodically review a plan of care for home health services (e.g., sign the plan of care); and (3) certify and re-certify that the patient is eligible for Medicare home health services. HHAs utilizing these providers will need to ensure that such providers are working within the scope of their practice under applicable state laws.
CMS has also waived the requirements for registered nurses to conduct onsite visits every two weeks, including the requirement to conduct an onsite visit to evaluate if home health aides are providing care to Medicare beneficiaries consistent with the care plan. Virtual supervision of home health aides is encouraged by CMS, but is not further described or defined in the waiver.
Medicaid Home Health Services
The IFC also amends the state Medicaid home health regulations to permit licensed practitioners other than physicians to order home health services during the COVID-19 public health emergency. Other practitioners, such as NPs and PAs, can order these services for Medicaid beneficiaries so long as they are ordered by the licensed practitioner in accordance with his/her state scope of practice laws. HHAs will need to review these requirements on a state-by-state basis to ensure that the licensed practitioner ordering this service is working within his/her scope of practice. This waiver is intended to align Medicaid’s rules with what is permitted by Medicare and will not expand the benefit categories where these items can be covered.
2. Hospices
Telehealth
For the duration of the public health emergency, CMS will permit hospice providers to provide services via telecommunications to Medicare beneficiaries who are receiving routine home care, but only if it is feasible and appropriate to do so in order for those beneficiaries to continue to receive services without jeopardizing the patient’s health or the health of those who are providing services. According to the IFC, the use of technology to provide those services must be included in the hospice plan of care and must be tied to patient-specific needs identified in the comprehensive assessment. No payment beyond the hospice per diem rate is provided—only in-person visits (other than social work phone calls) should be reported on the claim—but CMS does permit hospices to report the cost of telecommunications technology to furnish services as “other patient care services” as a specific COVID-19 cost center.
Also, face-to-face encounters for purposes of patient recertification for the Medicare hospice benefit can now be conducted by the hospice physician or NP via telecommunications technology during the COVID-19 public health emergency. This face-to-face encounter is an administrative encounter only. The telecommunications technology used as part of the encounter means, at a minimum, audio and video equipment permitting two-way, real-time interactive communication between the patient and distant-site hospice physician or NP.
Waiver of Volunteer, Non-Core and Supervisory Requirements
During the COVID-19 national emergency, CMS has waived certain requirements for hospices: (1) to use volunteers (including at least 5% of patient-care hours); (2) to provide certain non-core hospice services, including physical therapy, occupational therapy and speech-language therapy; and (3) to require a nurse to conduct onsite supervisory visits every two weeks, including the requirement to conduct an onsite visit to evaluate if hospice aides are providing care consistent with the care plan. CMS has acknowledged that these may not be physically possible for hospices to implement during widespread quarantine and stay-home orders.
Comprehensive Assessments
CMS has also temporarily changed required timeframes to update the patient-specific comprehensive assessment that identifies the patient’s need for hospice care and services for the duration of the COVID-19 national emergency. These must be completed as frequently as the condition of the patient allows, but no less frequently than every 21 days (up from every 15 days). An initial assessment must still be conducted within five days after the election of hospice care consistent with the Medicare Conditions of Participation.
Hospice Aides
CMS is temporarily relaxing certain requirements for hospice aide training and competency testing. First, CMS is waiving the requirement for hospices to assure that each hospice aide receives 12 hours of in-service training in a 12-month period. Second, CMS is temporarily allowing a hospice aide to use “pseudo-patients” (such as a computer-based mannequin or person trained to participate in a role-play situation) in competency training of certain tasks that must be observed being performed on a patient.
3. Other CMS Post-Acute Guidance and Resources:
- Advanced/Accelerated Payment: Post-Acute Providers who qualify are eligible for increased cash flow under Medicare’s Accelerated and Advance Payment Program. For more information regarding the qualifications for this program, see McDermott’s On the Subject article here.
- Stark Law Waivers/HHS, Office of Inspector General (OIG) Enforcement: CMS has provided 18 blanket waivers that will apply to arrangements in which a designated health services entity (DHS Entity), such as a home health agency, conveys a benefit directly to a physician or an immediate family member of a physician, or in which a physician (or immediate family member) conveys a benefit directly to a DHS Entity, so long as a COVID-19 purpose is met. The OIG issued a Policy Statement on April 3, 2020, indicating that it will not seek to impose administrative sanctions for arrangements protected under certain of the Stark Law blanket waivers. For more information, see McDermott’s On the Subject article here.
- Infection Control and Prevention Guidance: CMS has also issued Quality, Safety, and Oversight guidance regarding infection control and prevention for patients in the home care setting, for both HHAs and hospice agencies.
- Delay in Cost Reporting; Waiver of Quality Reporting Requirements: CMS has authorized delay of filing of Cost Reports. CMS will delay the filing deadline for October and November fiscal year end (FYE) cost reports until June 30, 2020, and the deadline for December FYE cost reports is extended until July 31, 2020.
- Waiver of Quality Reporting Requirements: Additionally, CMS has relaxed requirements under quality reporting programs. Home Health and Hospice Quality Reporting Programs deadlines for Q4 2019 data (October 2019–December 2019) are now optional. Consumer Assessment of Healthcare Providers & Systems (CAHPS) data from Q1–Q3 2020 (January 2020 through September 2020) does not need to be submitted to CMS.
- Suspension of Survey and Certification Activity; Revalidation: CMS is suspending all non-emergency survey inspections, and survey efforts are focused on immediate jeopardy events and complaints regarding infection control concerns. Finally, CMS is also temporarily ceasing revalidation efforts for all Medicare providers and suppliers during the COVID-19 public health emergency.